Delivery Order SPE2DB22D2009-SPE2DB25FL9DE

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,722.24 contract is for the supply of 4,567,916,244 units of the medication Dextroamphetamine-Amphetamine 10 mg capsules. The contract has an ultimate completion date of April 16, 2025 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,734.75, is for the supply of 4,567,861,597 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial...
This is a firm fixed-price delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,177,926 units of the prescription medication Dextroamphetamine-Amphetamine 10 mg capsules. The contract has a ceiling value of $1,252.90 and a period of performance through May 8, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a for-profit organization that has a significant...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,362.88 firm-fixed-price delivery order is for the supply of 4,568,192,443 units of the prescription medication Dextroamphetamine-Amphetamine 10 mg capsules. The contract has a period of performance extending through May 9, 2025 and was awarded on May 8, 2025. This delivery order is part of...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,433.08 fixed-price contract is for the delivery of 4,568,143,144 units of the prescription medication Dextroamphetamine-Amphetamine 10 mg capsules. The contract has a performance period through May 6, 2025 and is not set aside for any special type of business. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,059,549 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with a ceiling value of $2,525.52 and a performance period extending through April 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,030.09 firm fixed-price contract is for the supply of 4,568,084,803 units of the prescription medication dextroamphetamine-amphetamine 5 mg capsules. The contract has a performance period through May 1, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,286.50, is for the delivery of 4,567,926,421 units of Dextroamphetamine-Amphetamine 10 mg capsules. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,225.50 fixed-price contract is for the delivery of 4,568,188,726 units of the prescription drug dextroamphetamine-amphetamine 20 mg capsules. The contract has a performance period through May 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a $1,596.95 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 10 mg dextroamphetamine-amphetamine capsules, with a performance period through June 2025. This delivery order is placed under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL9DE
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,099.46, is for the delivery of 4,568,189,975 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract has a performance period through May 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization and a long-standing vendor for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/10/25, 1:16 AM